This article is one-sided in claims about the benefits of hormone replacement therapy (HRT) while dismissing current evidence and quoting only doctors who are advocates about using HRT. The article demonstrates examples of disease mongering language and lacks any quotes from doctors who disagree with the two doctors quoted – quotes/doctors that wouldn’t be difficult to find.
It also contains several inaccuracies:
The Women’s Health Initiative (WHI) was not designed to study HRT in women with menopausal symptoms, but, rather, to see if HRT had benefits – mainly for reducing risk of heart disease as a preventive approach for all menopausal women. The finding of increased cardiovascular risk was the big news of the WHI. However, later analyses of the same data, looking at younger menopausal women, have shown that heart risks do not apply to this subset of women.
Although some women may benefit from using HRT, these benefits should be framed with appropriate evidence from peer-reviewed sources and any discussion of HRT should also include a balanced discussion of risks.
There is no discussion of costs in the article.
Vague references to potential benefits of HRT with statements such as:
“(Drs) Johnson, Firouzbakht and other experts will tell you that hormone therapy protects against heart disease, a much more common killer of women than breast cancer, as well as against dementia, colon cancer, osteoporosis and other health issues.”
First, who are these “other experts” and where are the appropriate references for these claims?
Second, re-analysis of the data from the Women’s Health Initiative study shows:
The article states that conclusions of the Women’s Health Initiative have been discredited by subsequent studies but fails to state any of these studies or acknowledge potential side effects of HRT. The article instead points out some of the limitations of the Women’s Health Initiative, but we don’t think “discredit” is appropriate in this case. It was further analysis of the WHI data – not new studies – that showed that risks are different in the younger postmenopausal women (women in their 50s) compared with the older population.
The article contains quotes from two doctors who are very pro-HRT (one published a book about HRT), but the article itself only presents anecdotes and provides no references to actual studies showing benefits of HRT.
The article presents several examples of disease mongering language as applied to menopause:
” It’s not a death sentence or a dependence…”
” You don’t have to suffer..”
” treatment can enable and boost a woman’s overall day-to-day existence”
” Too many women have been taught to accept suffering in this stage of life”
There was clear imbalance in the story. The article only presents quotes from two doctors who were supportive of HRT. It also failed to identify sources for some of the claims in the article.
The article was only focused on HRT and did not discuss any alternatives.
HRT is available from your doctor, but at the end of the article, there is a statement that Dr Firouzbakht “prescribes pharmaceutical hormones and also works with a pharmacy she trusts to develop bio-identical hormone combinations for some patients. Such custom compounds are not FDA-approved.” The article goes on to state:
“It doesn’t matter what formulation of the hormones you are using, it’s the surveillance of it all that is very important,” Firouzbakht says.
These statements are confusing about the actual availability of HRT and hormones and dismisses the importance of FDA approval.
There is nothing novel about the approaches described in the story.
We don’t see any evidence that the story relied solely or largely on a news release.